Genetics of Familial and Sporadic Pancreatic Cancer

Laura Delong Wood, Matthew B. Yurgelun, Michael S Goggins

Research output: Contribution to journalArticle

Abstract

In the previous decade, comprehensive genomic analyses have yielded important insights about the genetic alterations that underlie pancreatic tumorigenesis. Whole-exome and whole-genome sequencing of pancreatic ductal adenocarcinomas have confirmed the critical driver genes altered in the majority of pancreatic cancers, as well as identified numerous less frequently altered driver genes, and have delineated cancer subgroups with unique biological and clinical features. It is now appreciated that pancreatic susceptibility gene alterations are often identified in patients with pancreatic cancer without family histories suggestive of a familial cancer syndrome, prompting recent efforts to expand gene testing to all patients with pancreatic cancer. Studies of pancreatic cancer precursor lesions have begun to elucidate the evolutionary history of pancreatic tumorigenesis and to help us understand the utility of biomarkers for early detection and targets to develop new therapeutic strategies. In this review, we discuss the results of comprehensive genomic characterization of pancreatic ductal adenocarcinoma and its precursor lesions, and we highlight translational applications in early detection and therapy.

Original languageEnglish (US)
Pages (from-to)2041-2055
Number of pages15
JournalGastroenterology
Volume156
Issue number7
DOIs
StatePublished - May 1 2019

    Fingerprint

Keywords

  • Gene Testing
  • Mutation
  • Pancreatic Cancer
  • Progression Model

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this